Loading
Total declarations
Company
▲ Purchases (1 ops.)
▼ Sales (0 ops.)
Latest filing published 17 Jun 2026 for Ironwood Pharmaceuticals INC.
Filing timeline
BuySaleJon R. Duane
Insider track record
Disclosed buys
1
Disclosed sells
0
T+90 hit rate
0%
T+90 mean return
-25.1%
Across 1 buy signal with a settled T+90 return. Return basis: close on the day after publication.
Signal history
Jon R. Duane: trading record in brief
All filings by Jon R. Duane on record concern Ironwood Pharmaceuticals Inc, in the capacity of board member. In total, 10 filings cover trades dated from 1 April 2019 to 16 June 2026.
Every open-market trade on record is a purchase: 1 purchase worth €55k, and no sale. A purchase on the market is a deliberate choice to commit personal money, which is why it draws more attention than a grant. Outside the open market, there are 9 share grants.
Most recently, on 17 June 2026, the filings show a share grant in Ironwood Pharmaceuticals Inc. The most recent open-market purchase was published on 8 March 2024, 962 days ago. Between a trade and the moment it shows up on SEC (Form 4), the median delay is 2 days. Section 16 rules allow two business days to file each Form 4. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.
Companies and markets linked to Jon R. Duane
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations7 total
63,481 sharesClass A Common StockSEC:0001193125-26-274283:0
45,000 shares0Class A Common StockSEC:0000950170-25-085443:0
24,311 shares0Class A Common StockSEC:0000950170-24-076209:0
6,920 shares@ US$8.70100.0% of flowClass A Common StockSEC:0000950170-24-028623:0
Canonical exit: 4 Jun 2024 (T+90)
22,350 shares0Class A Common StockSEC:0001209191-23-039135:0
21,571 shares0Class A Common StockSEC:0001209191-22-033980:0
22,766 shares0Class A Common StockSEC:0001209191-21-038194:0
7 of 7 declarations
